REZDIFFRA: payments to doctors
Payments that named REZDIFFRA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $18.2M
- Providers
- 20,116
- Transactions
- 81,642
- Average per transaction
- $223
The per-transaction average — $223 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 20,116 providers the average total is $905, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Madrigal Pharmaceuticals | $18,208,932 | 100.0% |